| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Bonstein Sara is a Chief Financial Officer at Ayala Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $10.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | INSM Insmed Inc | Chief Financial Officer | Sell | 6,000 | $65.43 | $392,601.72 | -1.7% | -0.7% | +169.7% | |
| May 29, 2024 | INSM Insmed Inc | Chief Financial Officer | Sale+OE | 241,288 | $50.00 | $12,064,607.24 | -34.6% | +44.0% | +29.2% | |
| May 14, 2024 | INSM Insmed Inc | Chief Financial Officer | Sell | 11,088 | $25.32 | $280,748.16 | -8.6% | +191.1% | +157.8% | |
| Jan 9, 2024 | INSM Insmed Inc | Chief Financial Officer | Sell | 4,497 | $29.18 | $131,222.46 | -3.8% | -3.4% | +125.8% | |
| Dec 22, 2023 | INSM Insmed Inc | Chief Financial Officer | Sell | 13,199 | $30.00 | $395,970.00 | -11.1% | -12.3% | +134.5% | |
| May 16, 2023 | INSM Insmed Inc | Chief Financial Officer | Sell | 3,820 | $18.95 | $72,389.70 | -1.6% | +21.3% | +35.6% | |
| Jan 10, 2023 | INSM Insmed Inc | Chief Financial Officer | Sell | 2,857 | $18.12 | $51,768.84 | -4.1% | -11.3% | +49.8% | |
| May 16, 2022 | INSM Insmed Inc | Chief Financial Officer | Sell | 1,433 | $18.51 | $26,524.83 | -2.6% | +39.1% | -6.7% | |
| Jan 11, 2022 | INSM Insmed Inc | Chief Financial Officer | Sell | 1,154 | $25.11 | $28,976.94 | -3.1% | -2.6% | -24.4% | |
| Jan 3, 2018 | ADXS Ayala Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 5,224 | $3.18 | $16,612.32 | -2.3% | - | - |